BTM	N1	N2	N3	N4	N5	N6	SI1	SI2	SI3	SI4	SI5	SI6integrin cell surface interactions (I) (M1.0)	-0.177	0.804	1.866	-1.473	-0.389	1.7	-0.92	0.187	0.54	0.874	-0.24	0.131extracellular matrix (I) (M2.0)	-1.286	-0.549	-0.84	-1.526	-0.32	0.196	-0.242	0.223	0.654	0.321	-0.071	-0.441extracellular matrix (II) (M2.1)	-0.285	-0.118	0.186	-0.154	0.14	0.158	-0.507	0.277	0.627	0.382	0.03	0.075extracellular matrix (III) (M2.2)	-1.286	-0.549	-0.84	-1.526	-0.32	0.196	-0.242	0.223	0.654	0.321	-0.071	-0.441regulation of signal transduction (M3)	-0.72	-0.381	0.097	-0.33	0.123	-0.341	-0.525	0.316	0.155	0.14	-0.126	-0.365cell cycle and transcription (M4.0)	-0.524	-0.063	0.181	-0.16	0.293	-0.102	-0.385	0.459	0.408	0.34	0.043	-0.189cell cycle (I) (M4.1)	0.386	0.546	0.078	0.19	-0.277	1.346	-0.036	0.243	-0.158	0.984	-0.356	0.172cell cycle (II) (M4.10)	-0.455	-1.165	-1.79	0.046	-0.789	0.752	-1.084	-1.765	-1.41	0.485	0.789	-1.657mitotic cell cycle in stimulated CD4 T cells (M4.11)	-0.13	0.072	0.227	-0.032	0.515	-0.074	0.012	0.643	0.582	0.427	0.195	-0.013C-MYC transcriptional network (M4.12)	0.453	0.333	-0.218	0.132	0.175	0.702	0.612	-0.16	-0.119	0.382	0.073	0.043cell junction (GO) (M4.13)	0.137	-0.039	0.11	-0.502	-0.583	0.444	-0.314	-0.822	-0.497	0.118	-0.22	0.057PLK1 signaling events (M4.2)	0.315	0.508	-0.026	0.226	-0.016	0.946	-0.24	-0.035	-0.294	0.03	-0.252	-0.04myeloid cell enriched receptors and transporters (M4.3)	-0.45	0.54	0.362	0.176	0.219	0.945	0.838	-0.856	0.07	-0.097	0.657	0.227mitotic cell cycle in stimulated CD4 T cells (M4.5)	1.011	1.336	0.144	0.925	-0.343	1.846	1.213	0.433	-0.849	0.804	-0.33	0.128cell division in stimulated CD4 T cells (M4.6)	-0.055	0.739	-0.531	0.496	0.185	-0.056	0.829	-1.824	0.414	-0.296	-0.124	0.36mitotic cell cycle (M4.7)	-0.416	0.27	0.652	-0.251	0.539	-0.022	-0.349	0.753	0.476	0.247	-0.047	-0.103cell division - E2F transcription network (M4.8)	0.361	-0.702	-0.404	-0.405	-0.467	-0.129	-0.395	0.217	-0.298	-0.565	0.356	-0.236mitotic cell cycle in stimulated CD4 T cells (M4.9)	-0.116	0.015	-0.083	-0.181	0.301	0.264	0.111	0.183	0.514	0.534	0.013	0.047regulation of antigen presentation and immune response (M5.0)	-0.17	0.031	0.277	-0.033	0.137	-0.089	-0.21	0.069	-0.158	-0.168	0.084	-0.067T cell activation and signaling (M5.1)	0.202	0.049	-0.054	-0.078	-0.23	0.3	0.259	-0.514	-0.575	-0.231	0.11	-0.057enriched in T cells (I) (M7.0)	0.32	-0.058	-0.454	-0.208	-0.691	0.499	0.431	-1.224	-0.701	0.021	-0.199	-0.073T cell activation (I) (M7.1)	0.218	-0.152	-0.238	0.001	-0.43	0.149	0.344	-0.789	-0.478	-0.153	-0.227	-0.054enriched in NK cells (I) (M7.2)	0.348	-0.09	-0.596	-0.932	-1.012	0.974	0.62	-1.344	-1.332	0.25	0.182	-0.336T cell activation (II) (M7.3)	0.318	0.265	0.225	-0.073	-0.323	0.738	0.381	-0.68	-0.48	0.301	0.118	-0.083T cell activation (III) (M7.4)	-0.023	-0.275	-0.436	-0.297	-0.732	0.089	0.123	-1.143	-0.525	-0.648	-0.371	0.174B cell development (M9)	-0.369	0.227	0.222	0.28	0.527	-0.435	0.044	0.483	0.657	-0.219	-0.367	-0.127E2F1 targets (Q3) (M10.0)	0.333	0.44	0.201	0.316	-0.201	0.523	0.05	-0.224	-0.159	0.224	-0.155	0.116E2F1 targets (Q4) (M10.1)	0.442	0.635	-0.122	0.647	-0.358	1.159	0.161	0.292	-0.15	0.679	-0.202	-0.076enriched in monocytes (II) (M11.0)	-0.645	-0.15	0.214	-0.244	0.258	-0.144	-0.432	0.324	0.436	0.27	0.009	-0.236blood coagulation (M11.1)	-0.82	-0.335	0.094	-0.57	-0.071	-0.184	-0.322	0.006	0.184	0.115	-0.077	-0.314formyl peptide receptor mediated neutrophil response (M11.2)	-0.548	-0.398	0.359	-0.211	0.363	-0.681	-0.647	0.344	0.397	-0.198	-0.122	-0.212CD28 costimulation (M12)	0.229	0.284	-0.136	-0.047	-0.361	0.41	-0.205	-0.794	-0.225	-0.231	-0.265	-0.165innate activation by cytosolic DNA sensing (M13)	0.3	0.898	1.163	1.005	1.043	0.017	-0.293	1.245	0.715	0.843	0.292	0.029T cell differentiation (M14)	0.215	0.084	-0.42	0.248	-0.64	0.14	0.216	-0.876	-0.137	-0.562	-0.31	0.347Ran mediated mitosis (M15)	0.45	0.547	0.243	0.653	0.327	1.628	-0.489	1.023	-0.103	0.82	0.112	-0.099TLR and inflammatory signaling (M16)	-1.219	-0.197	0.724	-0.538	0.101	-0.474	-0.919	0.309	0.191	-0.136	-0.103	-0.419T cell differentiation via ITK and PKC (M18)	0.19	-0.09	-0.252	-0.063	-0.76	0.523	0.164	-0.914	-0.76	-0.501	-0.272	0.249T cell differentiation (Th2) (M19)	0.168	0.141	0.181	0.291	-0.59	0.336	0.095	-0.539	-0.191	-0.085	-0.311	0.13AP-1 transcription factor network (M20)	-0.079	-1.923	-1.512	2.411	0.102	0.351	-2.021	-0.725	0.842	1.552	-0.434	0.62cell adhesion (lymphocyte homing) (M21)	-0.02	0.467	0.485	-0.348	-0.266	0.088	0.235	0.049	-0.248	-0.576	-0.165	0.069mismatch repair (I) (M22.0)	0.318	0.255	0.378	0.126	0	0.609	0.226	-0.054	-0.457	0.293	0.353	0.019mismatch repair (II) (M22.1)	0.532	0.224	-0.108	0.4	-0.041	0.608	0.564	-0.264	-0.115	0.379	0.21	-0.085"RA, WNT, CSF receptors network (monocyte) (M23)"	-0.406	-1.595	-0.822	0.651	0.182	-0.311	-0.966	-0.32	0.351	0.613	-0.429	0.255"cell activation (IL15, IL23, TNF) (M24)"	0.598	0.591	1.132	1.334	1.214	-0.629	-0.551	1.42	1.048	1.237	0.443	0.274TLR8-BAFF network (M25)	-0.917	-0.176	0.418	-0.441	0.234	-0.447	-0.892	0.652	0.261	0.054	-0.148	-0.022chemokine cluster (I) (M27.0)	0.415	-1.408	0.017	0.048	-0.808	0.866	-1.562	-0.775	0.231	1.036	-1.111	0.415chemokine cluster (II) (M27.1)	0.324	-0.077	0.398	-0.113	-0.18	0.891	-0.18	-0.199	-0.679	0.707	-0.11	-0.562antigen presentation (lipids and proteins) (M28)	0.398	0.372	0.014	0.066	-0.171	0.332	0.696	0.338	-0.163	0.405	0.454	-0.009proinflammatory cytokines and chemokines (M29)	0.486	-1.384	-1.085	1.411	1.395	-0.633	-1.633	0.12	1.478	1.171	-1.555	0.634"cell movement, Adhesion & Platelet activation (M30)"	-0.082	1.128	1.18	-1.318	-0.294	1.01	-1.01	0.403	0.99	0.591	-0.528	0.173cell cycle and growth arrest (M31)	0.112	-1.196	-0.019	1.445	0.325	-0.275	-1.226	0.333	1.133	1.24	-0.593	0.436platelet activation (I) (M32.0)	-0.21	-0.335	-0.411	0.091	0.103	-0.39	0.059	-0.288	-0.048	0.19	-0.329	-0.168platelet activation (II) (M32.1)	-0.203	-0.358	-0.363	-0.111	0.082	-0.393	-0.151	-0.43	-0.041	0.109	-0.291	-0.12CORO1A-DEF6 network (I) (M32.2)	0.049	-0.321	-0.507	0.274	0.032	-0.413	0.013	-0.585	0.101	0.087	-0.413	-0.08KLF12 targets network (M32.3)	-0.378	-0.499	-0.268	0.118	0.157	-0.608	0.077	-0.312	-0.225	0.207	-0.372	-0.238CORO1A-DEF6 network (II) (M32.4)	-0.117	-0.461	-0.407	0.281	0.109	-0.445	0.172	-0.5	0.047	0.086	-0.458	-0.135TBA (M32.5)	-0.062	-0.34	-0.486	-0.044	0.149	-0.409	0.035	-0.26	-0.384	0.087	-0.188	-0.01TBA (M32.6)	-0.166	-0.412	-0.283	0.078	0.11	-0.382	-0.114	-0.177	0.019	0.094	-0.233	-0.035TBA (M32.7)	0.206	-0.308	-0.613	0.23	0.138	-0.288	-0.023	-0.724	0.019	0.099	-0.422	0.12cytoskeletal remodeling (M32.8)	-0.223	-0.453	-0.357	-0.212	-0.105	-0.012	-0.23	-0.572	-0.308	-0.076	-0.137	-0.028inflammatory response (M33)	-0.578	0.175	0.324	0.033	0.364	-0.251	-0.143	0.654	0.447	0.582	0.062	-0.204cytoskeletal remodeling (enriched for SRF targets) (M34)	-0.74	0.516	0.687	-1.2	-0.213	0.646	-0.82	0.023	0.153	-0.051	-0.221	-0.376signaling in T cells (I) (M35.0)	1.02	-0.096	-1.163	2.142	0.809	0.89	-0.724	-0.399	0.512	1.74	-0.13	0.407signaling in T cells (II) (M35.1)	1.009	0.699	-0.473	-0.474	0.653	1.092	0.598	-0.942	-0.751	1.276	-0.062	-0.062"T cell surface, activation (M36)"	-0.005	0.071	0.058	0.079	0.246	0.07	0.128	0.329	-0.389	0.416	0.431	-0.202immune activation - generic cluster (M37.0)	-0.671	-0.147	0.282	-0.327	-0.006	-0.16	-0.557	0.089	0.219	0.106	-0.063	-0.143enriched in neutrophils (I) (M37.1)	-1.445	-1.191	-0.136	-0.875	-0.536	-0.968	-1.185	-0.523	-0.261	-0.449	-0.406	-0.347endoplasmic reticulum (M37.2)	-0.684	-0.359	0.188	-0.45	0.266	-0.387	-0.692	0.169	0.291	-0.279	0.076	-0.209cell division (M37.3)	0.331	0.435	-0.616	-0.081	-0.097	0.698	0.249	-0.689	-1.371	0.319	-0.542	0.379chemokines and receptors (M38)	0.502	-0.869	-0.388	0.369	0.15	0.062	-0.57	-0.063	-0.033	0.763	-0.464	0.369integrin mediated leukocyte migration (M39)	-0.396	-0.159	0.036	-0.355	-0.233	-0.111	-0.109	-0.36	-0.373	-0.237	-0.176	-0.234complement and other receptors in DCs (M40)	-0.404	-0.084	0.457	-0.952	-0.009	-0.514	-0.09	0.051	-0.263	-0.445	0.182	-0.425platelet activation (III) (M42)	-0.722	0.055	0.526	-0.288	0.109	-0.339	-0.415	0.253	-0.262	-0.26	-0.095	-0.155"myeloid, dendritic cell activation via NFkB (I) (M43.0)"	0.499	0.044	0.336	0.636	0.574	-0.553	-0.276	0.542	0.48	0.457	-0.117	-0.057"myeloid, dendritic cell activation via NFkB (II) (M43.1)"	-0.084	0.115	0.576	0.315	0.431	-0.282	-0.275	0.452	0.621	0.255	-0.015	-0.03T cell signaling and costimulation (M44)	-0.309	-0.076	0.106	-0.233	-0.15	-0.002	-0.3	-0.488	-0.032	-0.154	-0.283	-0.018leukocyte activation and migration (M45)	0.068	-0.01	0.116	-0.08	-0.189	0.127	0.032	-0.226	-0.318	0.071	0.018	-0.171cell division (stimulated CD4+ T cells) (M46)	-0.614	-0.018	-0.139	0.131	0.433	-0.459	-0.236	0.403	0.214	-0.326	-0.434	0.18enriched in B cells (I) (M47.0)	0.163	-0.408	-0.399	0.465	-0.742	-1.691	0.434	-0.524	-0.972	-2.221	0.044	0.633enriched in B cells (II) (M47.1)	-0.237	-0.048	-0.203	0.695	-0.426	-1.492	0.195	-0.286	-0.475	-1.904	0.377	0.62enriched in B cells (III) (M47.2)	-0.167	-0.127	-0.007	-0.039	-0.177	-0.578	0.015	-0.167	-0.172	-0.912	0.198	0.201enriched in B cells (IV) (M47.3)	-0.15	-0.212	0.079	0.605	0.016	-0.415	-0.105	-0.076	0.138	-0.746	0.458	0.614enriched in B cells (V) (M47.4)	0.199	0.151	-0.022	0.32	-0.197	-0.216	-0.329	0.266	0.314	-0.617	0.335	0.48TBA (M48)	-0.6	-0.273	-0.056	-0.12	0.077	-0.322	-0.129	0.133	0.125	-0.019	-0.156	-0.276transcription regulation in cell development (M49)	-0.285	0.011	0.239	-0.223	0.26	-0.226	-0.092	0.279	0.301	0.34	0.147	-0.086CD1 and other DC receptors (M50)	-0.935	-0.625	-0.773	-1.087	-0.284	-0.446	-0.712	-0.419	-0.38	-0.551	-0.68	0.26cell adhesion (M51)	0.016	0.232	1.093	-0.322	0.211	1.277	-1.284	0.448	0.897	1.393	-0.419	0.116T cell activation (IV) (M52)	-0.14	-0.22	-0.055	0.032	-0.017	-0.222	-0.177	-0.336	-0.089	-0.119	-0.061	-0.104inflammasome receptors and signaling (M53)	-0.136	0.279	1.083	0.163	0.685	-0.056	-0.533	1.093	0.538	0.547	0.091	0.078BCR signaling (M54)	-0.571	-0.189	0.07	-0.17	-0.132	-0.27	-0.277	-0.288	-0.171	-0.588	0.02	-0.036TBA (M55)	-1.102	-0.604	-0.249	-0.336	-0.106	-0.662	-0.574	-0.178	0.014	0.06	-0.235	-0.286suppression of MAPK signaling (M56)	-0.455	-0.651	-0.053	0.495	0.441	-0.369	-1.012	0.404	0.511	0.296	-0.297	0.047"immuregulation - monocytes, T and B cells (M57)"	1.031	-0.514	-0.749	1.485	-0.37	0.059	-0.302	0.107	0.022	0.924	-0.629	0.078B cell development/activation (M58)	-0.427	-0.13	0.108	0.158	-0.14	-0.478	-0.64	-0.046	-0.106	-0.75	-0.047	0.1"CCR1, 7 and cell signaling (M59)"	-0.637	-0.096	0.701	0.165	0.363	-0.477	-0.427	0.708	0.233	0.442	-0.107	-0.298lymphocyte generic cluster (M60)	0.359	-0.169	0.201	0.281	-0.435	0.239	0.388	-0.559	-0.633	-1.02	-0.089	0.464enriched in NK cells (II) (M61.0)	0.55	-0.331	-1.288	-0.997	-1.17	0.701	0.716	-1.744	-1.121	0.274	-0.07	-0.32enriched in NK cells (receptor activation) (M61.2)	0.345	-0.296	-0.739	-0.626	-0.721	0.479	0.43	-1.232	-1.04	-0.065	-0.087	-0.158"T & B cell development, activation (M62.0)"	0.363	0.231	-0.377	0.585	-0.395	0.012	0.477	-0.201	-0.211	-0.448	-0.077	0.05regulation of localization (GO) (M63)	0.08	-0.205	-0.324	0.16	0.307	-0.212	-0.122	-0.116	0.21	0.343	-0.334	-0.047enriched in activated dendritic cells/monocytes (M64)	-0.384	-1.091	0.068	0.236	0.138	-0.727	-1.109	-0.026	0.464	0.364	-0.14	0.13"IL2, IL7, TCR network (M65)"	-0.023	0.077	0.066	0.123	-0.227	-0.188	-0.009	-0.627	0.021	-0.384	-0.674	0.128TBA (M66)	0.068	0.211	0.338	0.161	0.653	0.348	0.161	0.751	0.832	0.819	0.059	-0.061activated dendritic cells (M67)	0.132	2.415	3.609	2.302	2.453	-0.037	-0.496	3.35	1.955	2.354	1.726	0.631RIG-1 like receptor signaling (M68)	0.334	0.702	1.455	1.721	1.757	-0.476	-0.805	1.965	1.378	1.614	0.239	0.365enriched in B cells (VI) (M69)	0.193	-0.302	-0.408	0.5	-0.58	-1.673	0.514	-0.419	-0.961	-2.111	-0.098	0.657TBA (M70.0)	-0.512	0.207	0.407	0.068	0.149	0.182	-0.519	-0.229	0.757	0.696	-0.409	-0.288TBA (M70.1)	-0.859	-0.542	-0.459	-0.213	0.096	-0.548	-0.706	-0.497	0.106	0.047	-0.214	-0.316enriched in antigen presentation (I) (M71)	0.401	-0.375	-0.148	0.039	0.479	-0.115	-0.083	0.307	0.125	0.039	0.08	0.095TBA (M72.0)	-0.289	0.126	0.563	-0.387	-0.058	0.19	-0.413	0.309	-0.109	-0.377	0.198	-0.186TBA (M72.1)	-0.218	0.029	0.471	-0.326	-0.077	0.142	-0.52	0.325	-0.112	-0.48	0.283	-0.178TBA (M72.2)	-0.325	-0.108	0.492	-0.463	-0.22	0.088	-0.594	0.199	-0.059	-0.504	0.18	-0.264enriched in monocytes (III) (M73)	-0.448	-0.546	0.752	0.662	0.526	0.035	-0.756	0.707	0.686	0.79	0.051	0.121transcriptional targets of glucocorticoid receptor (M74)	0.019	-0.379	-0.307	0.254	-0.356	-0.289	0.022	-0.714	-0.594	-0.813	0.182	0.338antiviral IFN signature (M75)	-0.289	1.761	2.859	1.746	2.078	-0.346	-0.61	2.648	1.452	1.743	1.332	0.57DNA repair (M76)	0.5	0.22	0.118	0.23	0.099	0.774	-0.024	0.088	-0.314	0.34	0.028	-0.034"collagen, TGFB family et al (M77)"	-0.268	-0.414	-0.278	-0.24	-0.789	-0.124	-0.05	-0.615	-0.024	-0.572	-0.767	-0.018"myeloid cell cytokines, metallopeptidases and laminins (M78)"	-1.228	0.504	0.516	-0.144	0.832	0.128	-0.591	0.091	0.538	0.587	-0.551	-0.508TBA (M79)	-1.063	-0.462	0.246	-0.939	0.037	-0.468	-0.676	0.037	-0.045	-0.225	0.008	-0.187TBA (M80)	-0.068	0.575	0.917	0.006	-0.295	0.247	0.006	0.354	0.416	-0.858	0.341	0.289enriched in myeloid cells and monocytes (M81)	-0.711	0.076	0.948	-0.884	0.084	0.351	-0.863	0.445	0.007	0.348	-0.215	-0.023enriched in naive and memory B cells (M83)	-0.103	-0.411	-0.42	0.343	-0.499	-1.229	-0.205	-0.337	-0.666	-1.559	0.221	0.585integrins and cell adhesion (M84)	-0.114	-0.24	-0.249	-0.387	0.025	-0.195	-0.174	-0.117	-0.177	-0.173	-0.092	-0.309platelet activation and degranulation (M85)	-0.452	0.566	1.054	-1.166	-0.21	1.107	-0.816	0.41	-0.145	0.407	0.176	0.014chemokines and inflammatory molecules in myeloid cells (M86.0)	0.696	-0.114	0.88	1.126	0.796	0.157	-0.625	0.784	0.839	1.272	0.026	0.104"proinflammatory dendritic cell, myeloid cell response (M86.1)"	0.924	1.043	1.203	0.766	1.238	0.265	-0.402	1.201	0.988	1.11	0.162	-0.124transmembrane transport (I) (M87)	-0.8	-0.183	0.433	-0.529	0.175	-0.16	-0.401	0.525	0.303	0.384	0.096	-0.221leukocyte migration (M88.0)	-0.413	0.416	1.603	-0.273	0.624	-0.391	-0.489	0.928	0.156	0.871	0.158	-0.014enriched in hepatocyte nuclear factors (II) (M88.2)	-0.456	-0.003	-0.411	0.725	-0.394	-0.354	0.218	0.317	-0.128	0.383	0.244	-0.168putative targets of PAX3 (M89.0)	2.529	-2.323	-1.678	3.967	0.058	-0.623	-1.893	0.244	1.197	2.829	-0.12	1.7putative targets of PAX3 (M89.1)	2.142	-1.049	0.178	2.656	-0.019	-0.609	-0.91	0.537	0.872	1.85	0.408	0.116"adhesion and migration, chemotaxis (M91)"	-0.786	-0.132	0.469	-0.986	-0.429	0.635	-0.292	-0.463	-0.652	-0.208	-0.021	-0.505"lipid metabolism, endoplasmic reticulum (M92)"	-0.178	-1.159	-0.734	-0.522	-0.013	-0.445	-0.821	-0.237	0.464	-0.071	-0.695	-0.013TBA (M93)	1.212	0.478	-0.299	2.538	1.618	0.114	-0.61	0.994	2.618	2.623	-1.866	0.562"growth factor induced, enriched in nuclear receptor subfamily 4 (M94)"	0.616	-0.383	-0.18	1.587	0.537	0.174	-1.033	1.241	0.706	0.592	-0.185	0.322enriched in antigen presentation (II) (M95.0)	-0.028	0.063	0.531	-0.242	0.207	0.087	-0.174	0.431	-0.154	-0.104	0.262	-0.047enriched in antigen presentation (III) (M95.1)	0.26	0.091	0.681	-0.014	0.29	-0.029	-0.315	0.631	-0.198	-0.052	0.436	0.082enriched for SMAD2/3 signaling (M97)	-0.964	-0.769	-0.706	-0.431	-1.011	-1.564	-0.361	-1.036	-1.119	-1.697	0.24	0.111"MAPK, RAS signaling (M100)"	-0.246	-0.421	-0.412	0.056	-0.066	-0.413	0.025	-0.333	-0.113	0.06	-0.371	-0.058phosphatidylinositol signaling system (M101)	-0.377	0.163	0.391	-0.101	0.077	0.162	-0.474	0.214	-0.151	-0.44	0.281	-0.248TBA (M102)	0.73	-0.022	-0.448	0.451	-0.6	-0.718	0.698	-0.51	-0.688	-1.412	0.062	1.048cell cycle (III) (M103)	0.232	0.419	-0.09	-0.063	0.189	0.51	0.222	-0.342	-0.017	0.281	-0.191	0.117TBA (M104)	-0.149	0.001	1.244	-0.578	-0.482	0.624	-1.075	0.488	0.296	-0.244	-0.128	0.736TBA (M105)	-1.333	-0.015	0.585	-0.437	-0.326	-0.172	-0.816	0.515	0.221	0.112	-0.075	-0.233nuclear pore complex (M106.0)	0.327	0.193	-0.078	-0.075	-0.147	0.49	-0.222	-0.071	0.007	-0.29	0.034	0.314nuclear pore complex (mitosis) (M106.1)	0.101	0.016	-0.268	-0.266	-0.172	0.43	-0.159	-0.256	-0.124	-0.199	0.08	0.229"receptors, cell migration (M109)"	-0.111	0.121	0.6	-0.168	0.069	0.243	-0.094	0.122	0.16	-0.166	-0.393	-0.148axon guidance (M110)	0.942	0.156	0.382	-0.127	0.532	1.557	1.456	0.67	1.016	1.315	-0.635	-0.036viral sensing & immunity; IRF2 targets network (I) (M111.0)	0.049	0.681	1.11	0.729	1.128	-0.142	-0.094	1.478	0.724	0.495	0.484	0.341viral sensing & immunity; IRF2 targets network (II) (M111.1)	0.082	1.42	2.02	1.24	1.59	-0.354	-0.468	2.109	1.252	0.878	0.934	0.322complement activation (I) (M112.0)	-1.43	0.482	1.94	0.296	0.089	0.289	-0.43	1.197	1.018	0.971	0.474	0.028complement activation (II) (M112.1)	-0.084	1.65	2.75	-2.138	-0.137	2.141	-1.006	1.19	0.191	1.561	0.382	0.075golgi membrane (I) (M113)	-1.263	-0.774	0.489	-0.565	0.37	-0.612	-0.823	0.843	-0.08	-0.266	0.158	-0.883TBA (M114.0)	-1.065	-0.111	0.068	-0.539	-0.283	-0.393	-0.598	-0.097	0.035	-0.645	0.079	-0.448glycerophospholipid metabolism (M114.1)	-0.977	0.353	0.676	-0.304	0.305	-0.854	-0.883	0.522	0.417	-0.315	-0.051	-0.235cytokines - recepters cluster (M115)	0.549	0.756	1.392	0.329	-0.223	0.478	-0.4	1.025	1.006	1.458	0.827	0.909cell adhesion (GO) (M117)	-0.126	-0.365	-0.332	-0.152	-0.375	-0.269	-0.319	-0.678	-0.481	-0.358	-0.277	0.078enriched in monocytes (IV) (M118.0)	-0.806	-0.269	0.386	-0.489	0.141	-0.346	-0.8	0.276	0.194	-0.01	-0.077	-0.312enriched in monocytes (surface) (M118.1)	-0.5	-0.137	0.529	-0.423	0.354	-0.425	-0.671	0.493	0.484	0.053	-0.082	-0.159enriched in activated dendritic cells (I) (M119)	-0.109	-0.133	0.636	0.265	0.366	-0.8	-1.083	0.651	0.156	0.324	0.468	-0.083TBA (M120)	-0.358	-0.541	-0.425	0.203	-0.198	-0.543	0.102	-0.506	-0.214	-0.171	-0.381	-0.013TBA (M121)	0.029	0.696	1.109	0.722	0.624	0.234	-0.245	0.462	0.407	0.524	0.729	0.048enriched in B cell differentiation (M123)	0.059	-1.034	-1.411	-0.115	-1.304	-0.526	0.609	-0.999	-0.791	-0.573	-0.93	-0.289enriched in membrane proteins (M124)	-0.245	0.789	1.083	-1.239	0.224	0.311	-0.757	0.364	0.398	0.733	0.714	0.05TBA (M125)	-0.183	0.753	1.215	0.248	0.264	0.625	-0.42	0.526	1.371	1.139	-0.408	-0.275double positive thymocytes (M126)	-0.064	0.068	-0.31	0.211	-0.677	0.254	-0.19	-0.659	-0.197	-0.421	-0.486	-0.072type I interferon response (M127)	-0.106	2.269	3.189	2.031	2.412	-0.119	-0.663	2.978	1.826	1.944	1.778	0.758TBA (M128)	0.02	0.146	0.508	-0.237	0.046	0.447	-0.013	-0.12	-0.029	-0.284	-0.056	-0.073inositol phosphate metabolism (M129)	-0.178	0.228	0.687	-0.131	0.219	0.059	-0.576	0.413	0.028	-0.403	0.312	-0.239enriched in G-protein coupled receptors (M130)	0.037	-0.024	-0.392	-1.077	-0.212	1.361	0.5	-0.481	-0.982	-0.124	0.206	-0.379TBA (M131)	-0.393	0.593	1.082	-0.359	0.478	-0.051	-0.914	0.674	0.954	0.7	0.044	0.513recruitment of neutrophils (M132)	-1.505	-0.832	-0.166	-0.598	-0.627	-1.015	-0.935	-0.266	0.031	-0.765	-0.4	-0.56"cell adhesion, membrane (M133.0)"	0.272	-0.518	-1.656	-0.299	-2.19	-0.074	0.097	-0.679	0.25	-0.73	-0.302	-0.462"Membrane, ER proteins (M134)"	-0.675	-0.236	0.153	-0.464	-0.371	-0.851	0.149	0.15	-0.293	-0.722	0.153	0.072TBA (M136)	0.041	-0.143	-0.158	0.075	0.478	-0.218	0.051	0.101	0.13	0.568	-0.264	-0.155TBA (M137)	-0.11	0.004	0.486	-0.185	-0.022	0.167	-0.293	0.009	0.026	-0.33	0.262	-0.116enriched for ubiquitination (M138)	0.014	0.264	0.575	-0.116	0.013	0.316	0.181	-0.336	-0.129	-0.364	-0.064	-0.164lysosomal/endosomal proteins (M139)	-0.257	0.019	0.208	-0.24	0.42	0.091	-0.091	0.574	0.664	0.448	0.057	-0.182"extracellular matrix, complement (M140)"	-0.823	0.029	-0.087	-0.261	0.514	0.058	-0.502	-0.38	0.32	0.442	-0.096	-0.234TBA (M141)	-0.042	0.416	1.339	0.416	1.055	-1.194	-0.447	1.87	0.342	0.753	0.822	-0.283"nuclear pore, transport; mRNA splicing, processing (M143)"	0.454	0.127	-0.53	-0.377	-0.224	0.249	-0.25	-0.359	-0.273	-1.07	-0.167	0.138"cell cycle, ATP binding (M144)"	-0.132	0.21	0.537	-0.182	0.106	0.353	-0.178	-0.006	-0.047	-0.211	0.186	0.111cytoskeleton/actin (SRF transcription targets) (M145.0)	-1.553	-0.158	0.265	-1.366	-0.682	0.069	-0.981	-0.151	0.261	-0.211	-0.632	-0.477cytoskeleton/actin (SRF transcription targets) (M145.1)	0.028	1.151	1.896	-1.672	-0.489	1.829	-0.473	0.04	0.633	0.816	-0.12	-0.343MHC-TLR7-TLR8 cluster (M146)	-0.051	0.131	-0.077	-0.104	0.336	-0.466	-0.206	0.149	-0.472	-0.476	0.279	-0.061intracellular transport (M147)	-0.156	-0.091	0.109	-0.337	-0.152	0.131	-0.321	-0.287	-0.175	-0.444	0.12	0.013TBA (M148)	-0.203	-0.107	0.434	-0.185	-0.168	-0.09	-0.573	0.313	-0.124	-0.408	0.325	-0.096innate antiviral response (M150)	-0.32	1.853	2.948	1.932	2.286	-0.204	-0.456	2.661	1.508	1.667	1.901	0.448TBA (M151)	-0.019	-0.551	-0.597	-0.495	-1.014	0.105	0.357	-1.359	-1.026	-0.456	-0.441	-0.008TBA (source: B cells) (M152.0)	-0.46	-0.51	0.865	0.204	1.105	-1.46	-1.749	0.992	0.571	-0.219	0.111	0.228TBA (source: naive B cells) (M152.1)	0.038	-0.459	0.433	0.262	0.492	-0.924	-0.822	0.452	0.256	0.161	0.024	-0.126TBA (source: memory B cells) (M152.2)	-0.46	-0.51	0.865	0.204	1.105	-1.46	-1.749	0.992	0.571	-0.219	0.111	0.228TBA (M153)	-0.227	0.151	0.468	-0.248	0.036	0.355	-0.163	0.437	0.151	-0.238	0.271	-0.123G protein coupled receptors cluster (M155)	-0.625	-0.191	0.729	-0.55	0.022	0.292	-0.449	0.249	0.097	-0.039	-0.112	-0.295"plasma cells & B cells, immunoglobulins (M156.0)"	-1.301	-0.571	-0.866	0.832	-0.239	-0.867	1.457	-0.017	-0.653	-2.349	0.422	0.699"plasma cells, immunoglobulins (M156.1)"	-2.162	-2.606	-1.495	1.464	0.084	-1.084	1.836	-0.19	-0.667	-2.052	0.5	0.65enriched in NK cells (III) (M157)	0.507	0.344	-0.273	-0.216	0.124	0.552	0.313	-0.191	-0.442	0.136	-0.103	-0.109G protein mediated calcium signaling (M159)	-0.142	0.846	1.349	-0.526	-0.446	0.331	-0.843	0.753	0.32	0.223	-0.501	-0.048leukocyte differentiation (M160)	0.056	-0.644	-0.001	0.623	0.126	-0.916	-0.775	-0.012	0.157	0.076	-0.253	-0.061TBA (M161)	-0.016	0.398	0.768	-0.378	0.303	-0.166	-0.241	0.492	0.289	-0.051	0.401	0.18"plasma membrane, cell junction (M162.0)"	0.272	-0.518	-1.656	-0.299	-2.19	-0.074	0.097	-0.679	0.25	-0.73	-0.302	-0.462enriched in neutrophils (II) (M163)	-1.004	-0.875	-0.557	-0.474	0.004	-1.064	-0.706	-0.486	-0.362	-0.78	-0.168	-0.129enriched in activated dendritic cells (II) (M165)	-0.131	1.255	2.184	0.825	1.4	-0.21	-0.753	2.032	1.309	0.962	0.883	0.342enriched in cell cycle (M167)	0.276	0.314	0.201	-0.52	0.554	-0.545	-0.165	0.214	0.292	0.586	0.276	0.181enriched in dendritic cells (M168)	-0.539	-0.133	0.576	-0.577	0.192	-0.158	-0.687	0.641	0.232	0.142	0.104	-0.027mitosis (TF motif CCAATNNSNNNGCG) (M169)	0.173	0.668	0.419	0.125	0.098	0.372	0.525	0.285	-0.357	0.028	0.278	-0.146heme biosynthesis (I) (M171)	1.006	1.435	1.399	-0.987	1.106	-0.301	-0.35	0.895	0.721	0.86	0.464	1.115erythrocyte differentiation (M173)	0.567	1.227	1.248	-0.752	1.182	-1.056	0.128	0.813	0.552	1.468	1.49	0.644TBA (M174)	-0.004	0.25	0.235	-0.102	-0.13	0.324	-0.062	0.157	-0.004	-0.35	0.028	-0.055TBA (M177.0)	0.084	0.206	0.581	-0.53	0.429	0.054	0.035	0.456	-0.081	-0.023	0.304	-0.222TBA (M177.1)	0.091	0.898	0.839	-1.088	1.007	1.428	0.157	0.642	-0.256	0.503	0.152	-0.438enriched for promoter motif NATCACGTGAY (putative SREBF1 targets) (M178)	0.106	0.458	0.656	0.625	-0.473	0.582	-0.532	0.235	0.401	-0.349	0.081	0.095enriched for TF motif PAX3 (M179)	0.202	0.37	0.255	-0.148	-0.414	-0.016	-0.332	-0.107	0.197	-0.795	-0.252	-0.096TBA (M180)	-0.104	-0.18	0.761	-0.558	0.047	0.319	-0.54	0.516	-0.334	-0.426	0.2	-0.139nucleotide metabolism (M181)	0.188	0.884	0.125	-0.083	0.119	0.632	0.478	0.003	-0.949	0.558	0.081	-0.378enriched in DNA interacting proteins (M182)	0.197	0.733	0.019	0.168	-0.01	0.932	0.592	0.149	-0.182	0.529	-0.314	-0.065TBA (M183)	-0.182	1.514	2.561	0.29	1.012	0.507	0.034	0.375	0.517	1.045	-1.054	-1.129TBA (M184.0)	0.296	0.255	0.531	0.111	0.293	-0.263	-0.43	0.199	0.853	0.77	0.211	0.137TBA (M185)	0.138	0.327	0.477	-0.151	0.144	0.391	-0.301	0.362	0.005	-0.101	0.053	-0.078TBA (M186)	-0.074	0.49	0.654	0.006	0.075	0.27	-0.51	-0.562	0.824	0.911	-0.3	0.034TBA (M188)	0.098	-0.181	-0.447	-0.029	-0.672	0.02	0.668	-0.947	0.231	-0.034	-0.182	0.157TBA (M190)	0.289	0.21	0.509	0.616	0.143	0.386	-0.193	0.238	0.812	0.686	-0.433	-0.134transmembrane transport (II) (M191)	0.354	0.029	0.112	-0.455	-0.296	0.15	-0.422	-0.264	-0.016	-1.117	-0.182	0.191TBA (M192)	-0.02	-0.051	0.268	0.075	0.598	-0.088	-0.115	0.291	0.226	0.318	-0.221	-0.025TBA (M193)	1.145	1.253	2.02	-1.316	1.618	-0.545	-0.987	1.552	0.971	1.581	1.277	0.82TBA (M194)	0.042	0.296	0.505	-0.278	0.045	0.318	0.083	-0.148	-0.067	-0.264	0.198	-0.246platelet activation - actin binding (M196)	-0.013	1.266	1.974	-1.374	-0.167	2.031	-1.012	0.736	0.857	1.142	-0.033	0.02TBA (M198)	-1.277	-0.932	-0.689	-0.489	-0.498	-0.877	-0.623	-0.226	-0.371	-0.598	-0.294	-0.224platelet activation & blood coagulation (M199)	0.64	1.334	2.392	-1.398	-0.166	1.516	-1.518	0.96	0.916	0.694	-0.072	0.702antigen processing and presentation (M200)	0.626	0.12	-0.269	0.083	0.357	0.158	-0.286	0.424	0.581	0.469	-0.424	0.699TBA (M201)	2.335	1.204	1.374	-0.312	0.876	-1.308	0.507	1.2	0.641	1.358	0.786	0.71TBA (M203)	-0.623	-0.063	0.206	0.09	-0.399	0.111	-0.229	-0.753	0.091	-0.954	0.428	0.311chaperonin mediated protein folding (I) (M204.0)	0.471	0.409	0.591	0.12	0.07	0.337	0.272	0.073	-0.089	0.328	0.124	0.221chaperonin mediated protein folding (II) (M204.1)	0.615	0.475	0.747	0.145	0.2	0.359	0.082	0.277	-0.062	0.261	0.202	0.159TBA (M205)	0.063	-0.208	0.306	-0.391	-0.023	0.269	-0.195	0.069	-0.199	-0.675	-0.117	0.088TBA (M208)	0.063	-1.032	0.351	-0.953	-0.325	1.265	-0.532	0.405	0.179	-0.051	0.553	0.137lysosome (M209)	0.054	0.649	0.77	-0.302	1.01	0.38	0.217	1.185	0.715	0.883	0.541	-0.14"extracellular matrix, collagen (M210)"	-0.975	-0.332	-0.272	-0.596	-0.322	0.161	-0.06	-0.093	-0.796	-0.149	0.101	-0.546TBA (M211)	-0.026	0.026	0.064	-0.511	-0.511	0.467	-0.272	-0.159	0.043	-0.343	-0.011	-0.066purine nucleotide biosynthesis (M212)	0.404	0.482	0.129	0.227	-0.36	0.473	0.425	-0.167	-0.647	0.666	0.234	-0.441"regulation of transcription, transcription factors (M213)"	-0.421	-0.039	0.629	-0.414	-0.044	0.025	-0.368	0.083	-0.056	-0.601	0.003	-0.174TBA (M214)	-0.585	-0.043	0.625	-0.506	-0.169	0.153	-0.569	-0.038	-0.181	-0.576	0.004	-0.256small GTPase mediated signal transduction (M215)	-0.508	-0.551	-0.226	-0.101	-0.037	-0.488	-0.288	-0.264	-0.198	-0.236	-0.312	-0.26respiratory electron transport chain (mitochondrion) (M216)	0.642	0.323	-0.121	0.569	0.071	0.502	0.708	0.259	0.279	0.47	0.102	0.069TBA (M218)	-0.445	0.563	0.427	-0.006	0.229	0.746	0.314	0.63	0.487	-0.624	0.115	-0.083respiratory electron transport chain (mitochondrion) (M219)	0.497	0.306	-0.353	0.347	0.124	0.539	0.377	0.03	0.149	0.367	0.18	0.003TBA (M220)	-1.389	-1.685	-3.718	-3.327	0.728	1.095	-0.364	-1.666	-3.026	-1.056	0.54	0.356heme biosynthesis (II) (M222)	0.244	0.826	0.059	-0.239	0.492	0.18	-0.322	0.422	0.737	0.115	-0.56	0.366enriched in T cells (II) (M223)	0.046	-0.241	-0.624	-0.577	-1.216	0.708	0.453	-0.872	-1.28	-0.533	0.023	-0.15proteasome (M226)	0.513	0.912	0.695	0.374	0.755	0.633	0.341	0.759	0.349	0.707	0.378	0.235translation initiation (M227)	0.391	0.302	0.213	0.26	-0.012	0.548	0.267	0.235	0.398	0.269	0.267	0.031TBA (M229)	0.464	0.408	0.327	-0.255	0.012	0.316	0.376	0.26	-0.315	0.027	0.182	-0.269"cell cycle, mitotic phase (M230)"	-0.129	-0.003	-0.142	-0.314	-0.548	0.372	-0.558	-0.405	-0.579	-0.309	-0.291	0.337respiratory electron transport chain (mitochondrion) (M231)	0.337	0.183	-0.146	0.147	-0.035	0.318	0.635	-0.44	-0.091	0.347	-0.012	0.121enriched for TF motif TNCATNTCCYR (M232)	0.485	-0.001	0.022	-0.124	0.19	0.038	0.105	0.042	-0.168	-0.333	0.162	0.124"transcription elongation, RNA polymerase II (M234)"	0.585	-0.117	-0.521	0.821	0.139	-0.262	0.219	-0.112	-0.206	0.575	-0.292	-0.015mitochondrial cluster (M235)	0.118	0.388	-0.021	0.178	0.069	0.337	0.724	0.07	0.171	0.115	-0.018	0.034TBA (M236)	-0.138	0.775	1.08	-0.187	0.808	0.405	0.656	0.894	0.162	-0.067	0.519	0.011golgi membrane (II) (M237)	-0.358	0.304	0.682	-0.16	0.186	0.296	-0.13	0.526	0.475	-0.162	0.175	-0.04respiratory electron transport chain (mitochondrion) (M238)	0.532	0.17	-0.432	0.467	0.225	0.298	0.229	0.151	-1.339	0.287	0.082	0.144TBA (M241)	0.304	-0.012	0.268	-0.117	-0.168	-0.605	0.034	-0.316	-0.457	-0.462	-0.106	0.163TBA (M242)	-0.337	-0.173	0.256	-0.397	-0.213	-0.163	-0.295	0.254	-0.283	-0.557	0.134	-0.236TBA (M243)	0.012	-0.189	-0.39	0.456	0.365	-0.11	-0.022	-0.014	0.549	0.35	-0.212	0.213translation initiation factor 3 complex (M245)	0.514	-0.122	-0.631	0.156	-0.221	0.144	0.579	-0.66	-0.219	-0.102	0.042	0.235enriched in nuclear pore complex interacting proteins (M247)	0.273	-0.438	-0.112	-0.013	0.07	-0.639	0.02	0.158	-0.276	0.013	0.046	-0.37TBA (M248)	0.685	-0.433	-1.069	0.724	0.378	-0.445	0.463	-0.209	0.479	0.591	-1.457	0.371TBA (M249)	-0.194	-0.086	0.284	-0.804	0.162	0.04	-0.477	0.345	-0.162	-0.641	0.539	0.199spliceosome (M250)	0.389	0.233	-0.372	0.601	-0.03	0.336	0.523	0.317	0.243	0.186	0.112	0.233T cell surface signature (S0)	-0.059	0.053	-0.19	0.398	-0.506	0.005	0.117	-0.691	-0.274	0.018	-0.205	0.053NK cell surface signature (S1)	0.009	0.291	0.21	-0.797	0.174	0.763	0.346	-0.321	-0.654	0.373	0.227	-0.426B cell surface signature (S2)	0.377	0.044	-0.023	0.41	-0.051	-0.742	0.128	-0.073	-0.197	-1.029	0.175	0.475Plasma cell surface signature (S3)	-0.122	0.226	0.595	0.15	0.276	0.185	0.072	0.622	0.254	0.617	0.112	0.258Monocyte surface signature (S4)	-0.84	-0.433	0.079	-0.567	-0.054	-0.322	-0.699	0.095	0.16	-0.088	-0.157	-0.328DC surface signature (S5)	0.058	0.532	1.123	-0.062	0.382	-0.288	-0.22	0.922	0.512	0.22	0.278	0.017CD4 T cell surface signature Th1-stimulated (S6)	1.94	1.07	1.119	-0.147	0.106	-2.082	1.171	1.17	-0.563	0.972	0.556	0.152CD4 T cell surface signature Th2-stimulated (S7)	-0.667	0.007	-0.032	0.273	-0.799	0.007	0.181	-0.797	-0.352	-0.093	-0.237	0.032Naive B cell surface signature (S8)	1.009	0.252	0.82	0.858	0.337	-0.527	-0.099	0.702	0.078	0.121	0.259	0.466Memory B cell surface signature (S9)	-1.039	-0.249	-1.107	0.469	0.191	-0.777	0.463	-0.346	0.621	-1.46	-0.133	0.379Resting dendritic cell surface signature (S10)	-0.358	-0.011	0.114	-0.344	0.211	-0.189	-0.347	0.473	0.259	0.286	-0.003	0.054Activated (LPS) dendritic cell surface signature (S11)	-0.394	0.441	1.308	0.05	0.645	-0.307	-0.564	1.109	0.498	0.175	0.507	-0.096targets of FOSL1/2 (M0)	-0.896	-3.374	-1.928	0.424	-0.342	0.205	-2.039	-1.877	0.418	1.679	-1.296	0.96